ロード中...
Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials
It is still controversial whether comprehensive genome screening of target molecules by next generation sequencing (NGS) is needed to increase clinical efficacy of investigational drugs or accelerate drug development, although several studies are being carried out. Therefore, we performed a prospect...
保存先:
| 出版年: | Mol Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5112718/ https://ncbi.nlm.nih.gov/pubmed/27852271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0553-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|